Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
9.14
+0.04 (0.44%)
Feb 3, 2026, 3:04 PM CST

SHE:002332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,3071,3821,6601,7201,2671,438
Trading Asset Securities
----500.64500.44
Cash & Short-Term Investments
1,3071,3821,6601,7201,7681,938
Cash Growth
0.65%-16.76%-3.51%-2.67%-8.79%84.59%
Accounts Receivable
947.56856.66726.38706.37752.24929.85
Other Receivables
60.3345.8615.4170.8417.6618.19
Receivables
1,008902.52741.79777.21769.9948.05
Inventory
919.02930.86922.88890.5910.7725.66
Other Current Assets
112.7148.4575.1646.11127.64137.01
Total Current Assets
3,3473,2643,4003,4343,5763,749
Property, Plant & Equipment
2,6892,5492,2572,0381,9971,925
Long-Term Investments
289.65303.56280.92278.26280.21281.93
Goodwill
643.72581.21606.96573.27557.57619.77
Other Intangible Assets
146.91151.07166.49177.18178.4184
Long-Term Deferred Tax Assets
31.128.7621.6228.6125.3927.26
Long-Term Deferred Charges
11.4711.210.1610.1912.5515.83
Other Long-Term Assets
104.98110.78249.99197.84101.1235.25
Total Assets
7,2637,0006,9936,7386,7286,838
Accounts Payable
371.77309.11484.51354.78385.31417.72
Accrued Expenses
57.6132.12127.86124.54175.4165.61
Short-Term Debt
129.568.511.0337.465.59310.77
Current Portion of Long-Term Debt
115.3114.75166.36102.4346.8293.07
Current Portion of Leases
-4.923.476.376.22-
Current Income Taxes Payable
71.1723.391128.4321.9442.35
Current Unearned Revenue
28.4930.6231.6846.8941.916.12
Other Current Liabilities
319.48254.67221.01268.26346.94373.18
Total Current Liabilities
1,093778.091,047969.071,3901,619
Long-Term Debt
24.2520.438.74193.85313.14574.45
Long-Term Leases
9.8810.389.754.47.49-
Long-Term Unearned Revenue
100.6997.2557.8654.5359.2853.84
Long-Term Deferred Tax Liabilities
---0.23--
Other Long-Term Liabilities
9.79205.299.538.498.318.75
Total Liabilities
1,2381,1111,1631,2311,7782,256
Common Stock
989.2989.2989.2989.2989.2989.2
Additional Paid-In Capital
1,8411,8411,8201,8031,8021,801
Retained Earnings
3,0383,0272,9262,6602,0591,586
Comprehensive Income & Other
124.22-13.5250.615.74-15.9868.46
Total Common Equity
5,9925,8445,7865,4574,8344,445
Minority Interest
33.244.6743.9250.01115.66137.42
Shareholders' Equity
6,0255,8885,8305,5074,9504,582
Total Liabilities & Equity
7,2637,0006,9936,7386,7286,838
Total Debt
27958.95219.36344.42739.251,178
Net Cash (Debt)
1,0281,3231,4411,3761,028759.77
Net Cash Growth
-13.87%-8.17%4.70%33.81%35.35%-
Net Cash Per Share
1.041.331.461.391.040.83
Filing Date Shares Outstanding
989.2989.2989.2989.2989.2989.2
Total Common Shares Outstanding
989.2989.2989.2989.2989.2989.2
Working Capital
2,2532,4862,3532,4652,1862,130
Book Value Per Share
6.065.915.855.524.894.49
Tangible Book Value
5,2025,1115,0134,7074,0983,641
Tangible Book Value Per Share
5.265.175.074.764.143.68
Buildings
-1,1541,112977.171,0251,026
Machinery
-2,0251,803275.361,5061,443
Construction In Progress
-714.85522.17374.2367.9250.42
Source: S&P Global Market Intelligence. Standard template. Financial Sources.